Viyash Scientific Ltd Q2 Results
- BSE: 512529
- NSE: VIYASH
- ISIN: INE807F01027
- Sector: Biotechnology & Drugs
BSE
261
-0.80 (-0.31%)
-0.80 (-0.31%)Volume90.96 K
Updated: Thu 10 Sep, 2026 | 15:16:38
NSE
260.15-1.75 (-0.67%)
-1.75 (-0.67%)Volume2.82 M
Updated: Thu 10 Sep, 2026 | 15:01:37
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Sep 25
Note: Comparison is on QoQ basis
Quarterly - Viyash Scientific Ltd Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 26 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 384.72 | 828.31 | -47.54% | 353.50 | 8.83% |
| Depreciation/ Amortization | 15.46 | 61.77 | -72.19% | 17.10 | -9.59% |
| Operating Income | 39.27 | 118.05 | -32.55% | 15.15 | 159.21% |
| Net Income | 14.74 | 65.87 | -53.66% | 2.61 | 464.75% |
| Other Operating Expenses Total | 72.77 | 169.64 | -53.73% | 69.75 | 4.33% |
| Net Income Before Taxes | 27.16 | 112.41 | -43.81% | 7.90 | 243.80% |
| Total Revenue | 423.99 | 946.36 | -46.44% | 368.65 | 15.01% |
| Selling/ General/ Admin Expenses Total | 81.69 | 162.65 | -41.14% | 67.04 | 21.85% |
| Diluted Normalized EPS | 0.63 | 1.47 | -16.44% | 0.23 | 169.84% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.